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The adaptive immune system recognizes billions of unique antigens using highly variable T-cell receptors. The ab T-cell
receptor repertoire includes an estimated 10
6 different rearranged b chains per individual. This paper describes a novel micro-
array based method that monitors the b chain repertoire with a resolution of a single T-cell clone. These T-arrays are
quantitative and detect T-cell clones at a frequency of less than one T cell in a million, which is 2 logs more sensitive than
spectratyping (immunoscope), the current standard in repertoire analysis. Using T-arrays we detected CMV-specific CD4+ and
CD8+ T-cell clones that expanded early after viral antigen stimulation in vitro and in vivo. This approach will be useful in
monitoring individual T-cell clones in diverse experimental settings, and in identification of T-cell clones associated with
infectious disease, autoimmune disease and cancer.
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INTRODUCTION
T cells are key players in the antigen specific immune responses.
Antigen specificity is provided by the T-cell receptor (TCR), which
is unique for each T-cell clone. Upon antigen recognition,
individual T cell clones generally expand and acquire differential
effector properties. Although the number of potential TCRs has
been estimated at 10
15 different a/b combinations [1], the actual
ab TCR repertoire per individual is estimated to include 10
6
different b chains [2], each pairing with a limited number of
a chains [3]. There is no rapid technology available that can
sensitively and quantitatively monitor this highly diverse T-cell
receptor repertoire.
Current technology for screening the TCR repertoire for
expanded T-cell clones relies on ‘spectratyping’ [4], often referred
to as immunoscope, and/or individual cloning and sequencing of
a sample of the T-cell population [2,5–9]. In spectratyping
analysis, PCR amplified TCR DNA is separated on size of the
CDR3 region. This approach separates the TCRb repertoire in
approximately 230 fractions, resulting from the use of ,23
primers for all functional Vb families and about 8 different CDR3
lengths per Vb [10]. A higher resolution can be attained when V-
and J-region primers are used; however, this requires 23 ? 13
individual PCR reactions, and results in a resolution of
approximately 23 ? 13 ? 8 peaks (Table S2).
Spectratyping itself generally does not identify individual T cell
clones, and is therefore often followed by repetitive cloning and
sequencing. Clonal peaks identified in the spectratype patterns are
sequenced, typically 10
2 clones and maximally 10
4 clones per
sample [2,5–9] in previous publications. The sensitivity of this
combined approach depends on the sensitivity of spectratyping for
identification of clonal peaks, and on the number of T-cell-
receptor rearrangements cloned and sequenced. Thus, although
the combination of spectratyping with sequencing can attain
sufficient resolution to analyze TCR diversity, the approach is
laborious and time consuming as it requires PCR amplification,
isolation of individual bands based on DNA size, purification,
followed by repeated cloning and sequencing.
Here, we explore a novel approach which exploits the high
capacity of DNA microarrays to monitor the expression of many
T-cell receptor rearrangements in parallel. At present, it can be
used to follow T cell responses in cases where type of Vb/Jb and
length of Jb-gene segment are available, e.g. from prior
immunoscope (spectratyping) experiments. The feasibility of this
approach is shown, and validated both in vitro and in vivo. We
show that T arrays quantitatively monitor the expansion of T-cell
clones after viral infection with high sensitivity (1 in 10
6 cells), and
with sufficient resolution to identify single clones in a background
of polyclonal peripheral blood T-cells. While at present it allows
monitoring a Vb/Jb-specific fraction of 0.03% of the T-cell
receptor repertoire on a single 4000-spot slide, the microarray-
based method can be scaled up to monitor and screen a large pool
of the T-cell repertoire for dominant clonotypes. We envision that
this sensitive and rapid technology will be useful for monitoring
and screening of clonal T-cell expansions for many applications in
medical research.
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Creating single-clone resolution
To create adequate resolution between different potential TCRs
we focussed on the highly variable complementarity determining
region 3 (CDR3) of the TCR beta chain. This region consists of
one out of 40–48 functional Vb and one out of 13 functional Jb
segments, joined by Db gene segments [11–13]. The CDR3 is
generated during VDJ-recombination by random deletion and
addition of nucleotides at the V-, D-, and J-junctions [1] and
produces the hypervariable NDN region, which can be used as
a signature for each TCR (Fig. 1A). We developed a T-array
protocol (Fig. 1C) to interrogate the first six nucleotides of the
NDN region and the length of the Jb-gene segment. Resolution is
created in three subsequent steps by: i)V b-specific PCR
amplification of the CDR3b (Fig. 1C1 and C2), ii) hybridization
of a labelled oligonucleotide (‘‘annealer’’) specific for the Jb-family
and for the number of Jb-nucleotides deleted (Fig. 1C4), and (iii)
a ligation reaction specific for the first six nucleotides of the
hypervariable NDN region on a universal hexamer microarray
[14], encoding all permutations of a hexamer nucleotide
(Fig. 1C5). In this way, the hexamer sequences on the array
complementary to the first six nucleotides of the NDN region of
a T-cell clone are ligated to the fluorescent annealer probes
(Fig. 1c6–7). The fluorescent signal of each hexamer sequence on
a single microarray chip, quantitatively reflects the expansion of
a certain T-cell clone. It should be noted that an annealer designed
for a Jb gene with n nucleotides deleted from the germline
sequence will also give a signal for TCRs with less than n
nucleotides deleted. The latter TCRs will reveal part of the
germline sequence of Jb in their hexamer sequences (1C4B).
The resolution of this T-array protocol depends on the number
of Vb and Jb segments, the size of the microarrays, and the
number of Jb-nucleotides deleted. To predict the potential
resolution of the assay we analyzed the distribution of N-deletion
in a random selection of 192 published CDR3b mRNA sequences
(Table S1). For 99% of the sequences a maximum of 10
nucleotides is deleted from Vb genes, and a maximum of 11
nucleotides from Jb genes (Fig. 1B). Within these limits, an almost
uniform distribution of the TCRs was observed over the number
of nucleotides deleted. This enabled us to predict the potential
resolution of the assay. Although the theoretical size of the TCR
repertoire is estimated at 10
15, extensive cloning experiments have
shown that within one individual the beta-chain repertoire
contains approximately 10
6 unique sequences [2], each of which
pairs with a limited number of a chains [2,3]. Based on these
numbers we estimate that after Vb/Jb-specific amplification on
average 10
6/1.4 ? 10
7=0.07 CDR3b sequences from the complete
repertoire of a human individual will ligate to a single sequence on
the universal hexamer microarray (see also Table S2C). In
theory, the assay should therefore have sufficient resolution to
detect single CDR3b sequences.
Testing sequence specificity and validity
The specificity of the protocol was tested using the T-cell clone
Jurkat E6-1, for which the CDR3 is known. After PCR
amplification of the Jurkat CDR3b region, we isolated the
antisense strand and hybridized it to a fluorescently labelled
oligonucleotide encoding the NDN-oriented end of the Jb1-2
sequence. Specificity of the ligation reaction for Jurkat NDN
sequence was then tested with hexamers either complementary or
not complementary to this NDN sequence (Fig. 2B–C). Only
in the presence of the complementary hexamer sequence (59-
GTTCGG-39) the annealer oligonucleotide was elongated, in-
dicating that the ligation is sequence specific for the Jurkat
CDR3b. Similarly, when the sense strand was used as a template,
the annealer was elongated only with the hexamer sequence
complementary to the 59-end of NDNb (Fig. 2D–E). When tested
on a universal hexamer array, out of all 4096 possible sequences
the Jurkat NDN sequence GTTCGG gave the strongest signal
(Fig. 2F–H). This shows that the protocol is sequence specific for
the T-cell clone analyzed. However, some other spots did produce
positive signals, albeit at much lower signal intensities, notably if
the encoded sequence was identical in the 39-end nucleotides
(NNTCGG). This suggests that, apart from the strongest signal at
hexamer GTTCCG, the Jurkat NDN sequence ligated to
hexamers with a 59-end mismatch.
Determination of sensitivity T-array
Having shown that the T-array is specific for the NDN sequence of
the analyzed T-cell clone we then compared the sensitivity of the
assay to that of spectratyping by diluting decreasing proportions of
Jurkat cells in a background of peripheral blood CD4
+ T-cells.
Semi-quantitative PCR showed that TCR transcripts in Jurkat
cells were not more abundant than in CD4+ cells obtained from
a healthy blood donor (Fig. S1). For immunoscope, Jurkat/CD4+
mixtures were then PCR amplified with a Vb12-sense primer and
a fluorescamine-labelled Cb reverse primer and size separated by
capillary electrophoresis (Fig. 3A). As expected, the size difference
between DNA peaks was 3 bp and the peak signals were normally
(Gaussian) distributed [5]. Only in the case of a dilution of 1 Jurkat
cell per 10
4 CD4
+ blood cells, the peak associated with Jurkat
CDR3b length (14 amino acids) is 47% of the total peak area. At
dilutions of 1 in 10
5 to 1 in 10
7 the peak associated with 14 amino
acids is 7–8% of the total peak area, and the peak distribution
remains normally distributed, indicating no dominance of any
CDR3 length in the Vb12 compartment. These results show that
the sensitivity of spectratyping is approximately 1 T-cells in 10
4
cells, which is in agreement with other reports [15].
For T-arrays, the antisense strands were isolated and hybridized
to the Jb-1-2-specific, Cy5-labeled oligonucleotide mentioned
earlier and ligated on a universal hexamer microarray (Fig. 3B–
C). In the case of a 1 in 10
5 to 1 in 10
7 Jurkat/CD4
+ ratio, the
hexamer sequence GTTCGG, which is complementary to the 39
end of Jurkat NDN region, was quantitatively picked up (Fig. 3C).
In the case of a 1 in 10
7 dilution, the GTTCGG signal was
similarly intense as the hexamer spots TGTCGG and CTTCGG.
These sequences only differ in the nucleotides at the terminal end
of the ligation product, suggesting that these are 59 mismatch
ligations of the Jurkat sequence. These results show that in this
format of the T-array protocol, individual T-cell clones are picked
up with a sensitivity of 1 clone in 10
6 T-cells.
Detection of expanding T-cell clones after viral
antigen stimulation
To test whether the T-array protocol would allow identification of
T-cell clones that expand upon antigen activation an in vitro
stimulation experiment was performed. Human peripheral blood
cells from a healthy HLA-A2
+ donor latently infected with the
b herpes virus CMV were isolated and stimulated with the CMV-
peptide NLVPMVATV. This 9-amino acid motif from the viral
structural protein pp65 dominates the cytotoxic T-lymphocyte
response against CMV [15]. In HLA-A2
+ individuals, the CD8
+
response to NLVPMVATV is Vb-restricted, in particular for but
not limited to Vb13
+ T-cells [16], which was in agreement with
spectratyping analysis of our donor (data not shown). FACS
analysis, using HLA-A2-NLV tetramer staining showed that the
T-Arrays
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increased after stimulation with NLV peptide (Fig. 4A). Before
stimulation (Day 0) a fraction of ,5% of the CD8
+ cells was
tetramer positive confirming CMV latency. Three days after
peptide stimulation CMV-reactive T-cells were not detectable by
FACS using tetramers, which can be attributed to TCR
internalization after MHC/peptide recognition [17]. During the
next 10 days, the fraction of tetramer-positive cells slowly
increased to ,60%. From day 6, spectratyping analysis revealed
that the Vb13
+ compartment became restricted to a CDR3 length
Figure 1. The T-array protocol. (A) During development, VDJ recombination causes enormous variability in TCRb chain by randomly selecting
different combinations of 23 V, 2 D, and 13 J gene segments, by nucleotide insertion ( ), and by nucleotide deletion from V ( ), D, and J ( )
genes. This results in a diversity of an estimated 10
6 different b chains per individual. (B) N-deletion causes shortening of the Vb and Jb segments. The
number of nucleotides deleted from Vb and Jb germline DNA is limited. N-deletion of 192 published TCRb mRNAs was determined. The figure shows
the cumulative percentage of CDR3bs for the number of nucleotides deleted. TCRb’s with n nucleotides deleted represent approximately 10% of the
repertoire if n=0 to 6, and 5%, if n=7 to 9. (C) The T-array protocol: (C1) cDNA from T-cells is generated. (C2) CDR3b regions are PCR amplified using
biotinylated Vb-specific ( )o rV b-generic primers (not shown here). (C3) Biotinylated strands are removed after alkaline denaturation using
streptavidin-coated beads. (c4) Single-strands of polyclonal TCRs are aliquoted and hybridized to fluorescently labeled annealers ( )
complementary to the NDN-adjacent end of a Jb gene. A specific number of Jb-gene nucleotides (n) is deleted for each annealer, accounting for
N-deletion during the VDJ recombination process. Insert (C4): Each annealer will hybridize to TCRb rearrangements where n nucleotides are deleted
from the Jb-germline gene segment (C4A) or where less than n nucleotides are deleted (C4B). (C5) The annealer-hybridized fractions are loaded on
universal hexamer arrays for (C6) T-cell-clone-specific ligation and, (C7) subsequently washed, scanned and analyzed.
doi:10.1371/journal.pone.0000055.g001
T-Arrays
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a single T-cell clone or only a limited number of clones in the
Vb13 compartment had expanded.
While Vb-13/Cb-spectratyping (Fig. 4B) or tetramer analysis
(Fig. 4A) only detected antigen-specific clones for CMV at day 6,
this clone was detected at day 3 using a more specific Vb-13/Jb-1-
2 spectratyping approach. The T-array, which was performed on
non-sorted T-cells, identified the CMV-specific T-cell clone
characterised by the NDN sequence CCTTTT already at day
0( Fig. 4C). To exclude aspecific effects of the primer and
annealer sequences used a T-array experiment was performed
using the same primers and annealer oligonucleotide on a different
sample; in this case no signal above background was observed at
the CCTTTT hexamer (data not shown). Further validation of the
CCTTTT hexamer sequence was acquired using extensive
cloning and sequencing (See below).
Hexamer sequences other than CCTTTT gave signals above
background intensity (Table S3, Fig. 4C). Of the top 100 signals
19 had a 39 CTA-end, identical to the terminal germline sequence
of the Jb-1-2 gene segment. These sequences derive from TCRs
that have no nucleotides deleted from the germline Jb-1-2 gene
(Fig. S2), and therefore give 59-(NNN)CTA-39 signals. Similarly,
sequences that have a (NNNN)TA-end (34 out of 100) or
(NNNNN)A-end (62 out of 100) derive from TCRs encoding the
germline Jb-1-2 gene with only one resp. two terminal nucleotide
deleted. Indeed, these signals derive from such TCR sequences as
shown by complete sequencing of these TCRb’s (see also below).
They can all be identified based on the terminal germline
nucleotide (here ‘‘A’’) in the hexamer sequence.
Validating T-array data by sequencing of multiple
T-cell clones
To test whether the T-array signal matches the frequency of these
T-cell clones as estimated by repetitive cloning and sequencing, we
sequenced Vb13
+/Jb1-2
+ TCRs from three samples of the
experiment shown in Figure 4 (Table S4). Out of 52 clones
sequenced from the Day 0 sample, 27 were found to have 3 or less
nucleotides deleted from the Jb-1-2 gene, and can therefore be
detected in the T-array shown in Figure 4. Fourteen of these
Figure 2. Ligation experiments with Jurkat CDR3b amplicons. (A) VDJ rearrangement of Jurkat TCRb. In this CDR3 sequence, there are 3 and
0 nucleotides deleted form the germline Vb and Jb, respectively. (B–E) Capillary-electrophoresis chromatograms showing length and signal of
fluorescent annealers ( ). (B) A hexamer (GTTCGG) complementary to the Jurkat 3-end NDN sequence elongated (*) the Jb1-2-specific annealer
(¤). (C) The non-complementary 59-end hexamer failed to cause elongation. Black peaks: Cy5 signal; Red peaks: FAM signal of size standards. (D, E)
Similarly, a Cy5-labeled oligonucleotide complementary to the 39 coding end of Vb12, was elongated (*) only in the presence of the hexamer
GTCGAG which is complementary to the 59-end of the NDN sequence. (F) Detail of universal hexamer array after ligation of a Cy5-labeled
oligonucleotide complementary to the 59 coding end of Jb1-2 in the presence of the antisense strand template of Jurkat CDR3b. (G) Signal intensities
of all 4096 spots of the same array experiment. The arrow in (F) and (G) indicates the microarray spot with sequence GTTCGG. (H) List of 20 strongest
spots with their hexamer sequence and Cy5-fluorescent signal.
doi:10.1371/journal.pone.0000055.g002
T-Arrays
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frequency (7/52) gave the strongest signals on the T-array
(hexamer sequences CCTTTT and GGACCG). One clone which
was detected at lower frequency (CAGCTA, frequency 2/52) also
gave a T-array signal well above background. Eleven clones were
detected with a frequency of only 1 out of 52. Three of these gave
T array signals above background (Table S5). Eight clones gave
signals similar to background, suggesting that the concentration of
these clones in the blood sample is below the detection limit of the
T-array. The clonal frequencies measured at day 3 were in
agreement with the expansion measured by the T-array, showing
that the T-array protocol quantitatively detects clonal expansion.
Application of T-array protocol for in vivo detection
To test the applicability of the T-array protocol for detection of
clones in vivo, we analyzed a well-characterized sample of FACS
sorted, CMV-specific, IFNc-secreting CD4
+ T-cells from a renal
transplant recipient 9 weeks after primary CMV infection, at the
peak of viral load [18]. This sample of 11,600 sorted CMV-specific
T-cells was pre-amplified by anchored PCR [19,20], which was
used here as pre- amplification step to generate sufficient cDNA
from a relatively small amount of RNA (Fig. 5A–B). Spectratyp-
ing indicated a relatively broad repertoire [18]. Within the
repertoire 11 Vb families were extensively analyzed by cloning
and sequencing [18]. In the Vb6.1 pool, 60 clones were
sequenced, revealing 12 unique sequences of which 4 were
Jb2.7
+. A T-array was performed to screen the Vb6.1- Jb2.7
subpopulation with an annealer oligonucleotide that detects Jb2.7
sequences with 3 or less nucleotides deleted from the Jb2.7 gene
(Fig. 5F). All 3 clones that meet these criteria were picked up with
the T-array (Fig. 5E, Table S5). In addition, the T-array signal
matched the clonal frequency of the T-cell clones identified. The
clone with hexamer CGGCTC which was picked up in 5 out of 60
sequences gave the strongest signal, followed by clone GAGGAA
(3 out of 60), and clone CCAGTC (1 out of 60), respectively.
These data show that the T-array can detect in vivo expanded
T-cell clones in a quantitative way.
DISCUSSION
The diverse repertoire of TCR rearrangements can potentially be
analyzed using microarrays, which have a high capacity to
differentiate and monitor many unique DNA rearrangements in
parallel. However, the size of the TCRb repertoire at the DNA
level is too large for full TCR repertoire analysis at single-clone
resolution on a single microarray. The ab receptor diversity is
estimated at 10
15 to 10
18 rearrangements [1,21], which is formed
for a relatively large part by the b chain. Within one individual,
however, the size of the b chain repertoire is much more limited
Figure 3. Spectratyping and T-array for Jurkat T-cell clone mixed with peripheral blood CD4
+ T-cells. Jurkat cells were added in different dilutions
to a background of peripheral blood CD4
+ T-cells. (panel A) CDR3 spectratyping with Vb12-specific primer. The arrow indicates a length identical to
14 amino acids, which is the length of the Jurkat CDR3b. (panel B) A detail of the T-array scans. White arrows indicate hexamer sequence GTTCGG,
which is complementary to the first six nucleotides Jurkat NDNb region. (panel C) Signal intensities of all 4096 spots of the T-array. Black arrows
indicate hexamer sequence GTTCGG.
doi:10.1371/journal.pone.0000055.g003
T-Arrays
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+ donor after antigen specific stimulation. (panel A) The fraction of antigen specific T-cell clones
determined with NLVPMVATV-loaded tetramers. (panel B) Spectratyping of unsorted Vb13
+ and Vb13
+/Jb1-2
+ fraction. (panel C) CDR3 sequence of
the clone identified compared to the Jb1-2 germline sequence. (panel D) T-array of unsorted Vb13
+/Jb1-2
+ fraction. The annealer oligonucleotide
used in this T-array experiment had the sequence ACTATGGCTACACCTTCGGTT, allowing detection of rearrangements with 3 or less nucleotides
deleted from the Jb1-2 germline. The arrow indicates sequence CCTTTT, the first nucleotides of the NDNb region of the dominant T-cell clone that
was identified in this screen.
doi:10.1371/journal.pone.0000055.g004
T-Arrays
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6) [2], and microarrays could produce sufficient resolution to
distinguish single T cell clones in the repertoire of one individual.
Here, we use universal microarrays for this concept and show that
this is feasible. In the design presented, T-arrays tag individual
clones based on the sequence information in the NDN-J or NDN-
V junction. The tag for each clone consists of the J- or V-family
used, the number of terminal nucleotides deleted from this J- or V-
gene segment and the first six nucleotides of the NDN region. This
design creates tags that are specific for one in more than a million
clones, which in theory allows single-clone analysis of the complete
TCRb repertoire on high-density microarrays.
The validity of the T-array protocol was shown in several
experiments. Firstly, the PCR fragments derived from the TCR of
Jurkat cells were selectively ligated to hexamer oligonucleotides
complementary to its NDN sequence both in solution and using
hexamer arrays (Fig. 2). Second, the protocol allowed early,
highly specific identification of an expanding T cell clone after in
vitro stimulation with CMV-peptide (Fig. 4). Third, T-cell clones
from blood taken form CMV-infected individuals that were
identified using T-arrays, were also detected by multiple cloning
and sequencing (Table S4). Lastly, in FACS-sorted CMV-
specific, IFNc-secreting CD4+ T cells from a renal transplant
patient 9 weeks after CMV infection T-arrays detected the
dominant Vb6.1
+/Jb2.7
+ clones identified earlier by extensive
cloning and sequencing (Fig. 5).
The sensitivity of the protocol was determined after mixing
a Jurkat T-cell clone in a background of peripheral blood CD4+
T-cells in a range of dilutions. The data show that the Jurkat TCR
rearrangement was detected in a ratio of at least 1 in 10
6 (Fig. 3).
This is 2 logs more sensitive than Vb-Cb spectratyping [4,15],
which can detect a T-cell clone in 1 in 10
4.V b-Jb spectratyping,
an alternative approach which is not widely used, is theoretically
12-fold higher than that of Vb spectratyping and therefore 10-fold
less sensitive than the T-array approach. The superior sensitivity of
the T array was confirmed by detection of a CMV-specific T-cell
clone which was identified in the unstimulated population of
circulating T cells obtained directly from a CMV-infected donor
(Fig. 3). This clone was only detected after 3 days of antigen
stimulation by Vb-Jb spectratyping and after 6 days by Vb-Cb
spectratyping (Fig. 4). Thus T-arrays make highly sensitive
detection and tracking of T cells possible. Figure 6 illustrates the
sensitivity of various methods for the analysis of the TCRb
repertoire.
In addition, the protocol allowed quantitative monitoring of T
cell clones. With decreasing numbers of Jurkat cells in a CD4
background the signal clearly decreased (Fig. 3). The increasing
frequency of the CMV-specific clone in the in vitro experiment as
evidenced by tetramer staining, and by spectratyping, was also
reflected in signal intensities on the arrays (Fig. 4). Likewise, the
observed clonal frequencies of the CMV-specific clones in the in
vivo experiment (Table S4) were quantitatively reflected in the
T-array data.
Although the ligation reaction is highly specific for the correct
hexamer sequence, ligation mismatches did occur. However, in
every instance true positives gave the strongest signal, even in
complex mixtures. Figure 2G supports previous data [14,22]
Figure 5. T-array analysis of CMV-specific cells in vivo. (A) Peripheral blood was drawn 9 weeks after primary CMV infection of a CMV-seronegative
renal transplant recipient, and sorted for CMV+ IFNc-producing T-cells. (B) cDNA was amplified using anchored PCR (ref. 20). (C) Vb’s were analyzed by
spectratyping and 11 Vb-families were cloned and sequenced (ref. 18). (D) The most prominent Vb/Jb combination as identified by (C), i.e. the Vb6.1/
Jb2.7+pool, was amplified by Vb6.1-and Jb2.7-primers and loaded on a hexamer array. (E) CDR3 regions, clonal frequencies, and joining sequences of
the identified Vb6.1/Jb2.7+T-cell clones. (F) Vb6.1/Jb2.7-specific T-array with the annealer CTACGAGCAGTACTTCGGG, which matches the germline Jb-
2-7 sequence with 3 nucleotides deleted.
doi:10.1371/journal.pone.0000055.g005
T-Arrays
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positions opposite of the site of ligation. Algorithms, based on
known ligation patterns [14,22], have been developed that identify
false positives and reduce the loss of resolution when complex
mixtures such as full-genome transcripts are analyzed on hexamer
arrays [14]. Such algorithms may help to minimize the effect of
cross ligations on the resolution of T-arrays and help to detect less
frequent clones.
The technology described here can be applied to monitor a small
selection of the TCRb repertoire quantitatively, and to track
a subset of T-cell clones sensitively and quantitatively. While the
combination of spectratyping, cloning and sequencing may take
several weeks, the T-array method takes only a single day
including scanning and quantification. Furthermore it is sensitive,
and allows monitoring of growth kinetics at the clonal level. This
rapid and sensitive method may find applications in the study of
the relation between clonal expansion of T cells and autoimmune
phenomena, e.g. responses to immunotherapy, retrospectively and
prospectively. Recurrence of autoimmune disease could be
predicted in the case of previously identified clones [23], or the
fate of T-cells in adoptive therapy against cancer [24] could be
monitored at single-clone level.
One of the prospects of this technology is that it could possibly
be developed into a tool that screens the complete TCRb
repertoire on a single array. The format presented here screens
only 1/23 ? 1/144=0.03% of the repertoire (Table S2C).
Recently, we successfully explored the feasibility of a protocol in
which T-array analysis is preceded by simultaneous amplification
of all Vb families in one PCR reaction using anchored PCR as
described earlier [19,20] (data not shown). The resulting 144
arrays can then be housed in a high-density matrix of multiple
arrays that can be individually loaded. Such matrices have recently
become available [25]. Rapid, quantitative and sensitive full
repertoire screening would have significant impact in immuno-
logical research and on the development of immunotherapeutics.
Identical arrays might be built for the analysis of the TCRa,- c and
-d repertoires and of the B-cell receptor repertoire in humans and
other species.
In conclusion, here we show proof of concept of an approach to
sensitively monitor changes in the frequency of unique TCR
rearrangements using microarrays. The protocol is rapid and
universal for the detection of all T- and B-cell receptor
rearrangements. We propose that this technology will be useful
for monitoring of clonal T- and B-cell expansions for many
applications in medical research.
MATERIALS AND METHODS
Analysis of CDR3 sequences from public database
TCR b-CDR3 mRNA sequences of human T-cell clones were
collected from the public database of NCBI at NIH. Vb-, Jb-, Db-
segments were identified using the V-QUEST algorithm from the
international ImMunoGeneTics information system [13]. A
number of 50 sequences were validated manually, and assignment
errors were identified only for N-deletions larger than 8
nucleotides. To exclude other assignment errors all CDR3b
sequences with N-deletions larger than 7 nucleotides were
therefore assigned manually.
Cells and flow cytometry
Jurkat cell line clone E6-1 (ATCC, Manassas, VA) was grown in
DMEM culture medium (Sigma-Aldrich, St. Louis, MO) supple-
mented with 5% FCS. Human peripheral blood mononuclear cells
(PBMC) (Figure 3) were isolated from buffy coats of healthy blood
donors by density centrifugation with Ficoll-Isopaque (Pharmacia
Biotech, Uppsala, S). Informed consent was obtained from blood
donors. CD4
+ T cells were isolated by using anti-CD4 microbeads
(Miltenyi Biotec, Bergisch Gladbach, D), followed by positive
selection with the VarioMACS (Miltenyi Biotec) according to the
manufacturer’s protocol. The purity of the CD4+ cells isolated was
measured using anti-CD4 PerCP-conjugated antibodies (BD
Biosciences, San Jose, CA).
Thawed PBMCs (Figure 4) were resuspended in IMDM
(BioWhittaker, Verviers, Belgium), containing 10% FCS and
antibiotics (100 U/ml sodium penicillin G and 100 mg/ml
streptomycin sulfate). Cells were washed in PBS containing
0.01% (w/v) NaN3 and 0.5% (w/v) BSA (PBA). A total of
250,000 PBMCs were incubated with an appropriate concentra-
tion of tetrameric complexes in a small volume for 10 min at 4uC.
Subsequently, fluorescently labelled conjugated mAbs (concentra-
Figure 6. Comparison of the diversity of the human TCRb repertoire and the sensitivity of various methods for repertoire analysis. (A) The
human T-cell repertoire contains an estimated 10
6 rearrangements per individual (ref. 2). (B) The sensitivity of Vb/Cb immunoscope is approximately 2
in 10
4 (ref. 15 and Fig. 3A). (C) Based on the number of Jb primers, it is estimated that Vb/Jb immunoscope is 12-fold more sensitive than Vb-Cb
immunoscope. (D,E) The sensitivity by which TCR rearrangements are picked by indivual cloning, depends on the number of clones sequenced (ref.
5–9). (F) The sensitivity of the T-array is approximately 1 in 10
6 rearrangements (Fig. 3C).
doi:10.1371/journal.pone.0000055.g006
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incubated for 30 min at 4uC. For analysis of expression of surface
markers, the following Abs were used: the allophycocyanin-
conjugated HLA-A2 tetramer loaded with the CMV pp65-derived
NLVPMVATV peptide [15], and anti-CD8 PerCP–conjugated
antibodies (BD Biosciences, San Jose, CA).
CMV-specific IFN-c-producing CD4+ cells from a renal trans-
plant recipient were isolated using IFNc Secretion Assay Detection
Kit (PE) (Miltenyi Biotec, Amsterdam, The Netherlands) accord-
ing to the manufacturer’s conditions. At the moment of peak viral
load, 9 weeks after transplantation, PBMCs were isolated and
stimulated for 16 hours with CMV antigen (10 ml/ml) and
incubated with IFNc Catch Reagent for 5 minutes at 4uC,
incubated with IFNc Detection Antibody (PE), CD4 APC (BD
Pharmingen, San Diego, USA) and sorted using FACsARIA (BD).
The patient had given written informed consent, and the local
medical ethics committee had approved the study.
Expansion of virus-specific autologous cytotoxic
T-lymphocytes
PBMCs from a CMV seropositive, HLA-A2
+ healthy volunteer
donor were used for expansion of CMV specific CD8
+ cells.
Informed consent was obtained from the blood donor. PBMCs
were stimulated in IMDM supplemented with 10% human pool
serum, antibiotics, and 2-ME with CMVpp65-A2 peptide
NLVPMVATV (1.25 mg/ml) and IL-2 (50 U/ml Biotest,
Dreieich, D) in 24-well plates. After one week, cells were
restimulated on a weekly basis with irradiated (30 Gy) CMV-
pp65-A2 peptide loaded EBV transformed cell-lines expressing
HLA-A2
+ (5610
4 cells/ml) in the presence of IL-2.
Cloning and sequencing
Vb PCR products were purified and ligated into pGEM-T Easy
Vector (Promega, Madison, WI) and cloned by transformation of
competent DH5a E. coli. Selected colonies were amplified by PCR
using M13 primers (Invitrogen - Life Technologies, Breda, NL)
and then sequenced on the ABI Prism 3730 DNA automatic
sequencer (Applied Biosystem, Foster City, CA) using the dye
terminator cycle sequencing chemistry (v1.1) (Perkin Elmer, Foster
City, CA). Clones that did not yield a PCR product using direct
colony-PCR, were cultured in LB medium, plasmid DNA was
purified using the Wizard Plus Minipreps DNA purification system
(Promega, Madison, WI), and plasmids were sequenced similarly
as described above.
PCR and Spectratyping analysis
RNA was isolated using the GenElute Mammalian Total RNA Kit
(Sigma-Aldrich, Zwijndrecht, NL). For experiments shown in
Figures 2, 3 and 4, cDNA was synthesized using Superscript RT II
and oligo-dT primers (Sigma-Aldrich) according to the manufac-
turer’s protocol (InVitrogen - Life Technologies, Breda, NL). For
experiments shown in Figure 5, cDNA was synthesized using the
Super Smart
TM and the Smart
TM cDNA synthesis kit (Clontech,
Mountain View, CA), respectively. PCR was performed with TCR
Vb primers [26] in combination with a TCR Cb primer, labelled
with fluorescent dye fluorophore fluorescamine (FAM). Each
amplification reaction was performed with 4 ml cDNA in the
presence of 25 pmol 59 sense TCR Vb primer, 25 pmol 39
antisense TCR Cb primer, 0.5 mM MgCl2, 0.5 mM dNTP,
10 mM Tris–HCl (pH 8.4), 50 mM KCl, 4 mM KCl, 2.5 units
AmpliTaq DNA polymerase (Perkin Elmer/Roche Molecular
Systems Inc., Branchburg, NJ) in a total volume of 40 ml. PCR
cycles were performed in a T1 Thermocycler (Biometra,
Goettingen, D). The FAM-labelled PCR products were run on
the ABI Prism 3100 Genetic Analyzer capillary system (Applied
Biosystem, Foster City, CA) using POP6 as separation matrix,
filter set D for the detection of fluorescent signals, and ROX500 as
internal size standard. Genescan Software (Applied Biosystem,
Foster City, CA) was used for size determination and quantifica-
tion.
T-array protocol
After cDNA synthesis (1C1), the T-array protocol follows PCR
amplification (1C2), isolation of polyclonal, single strands (1C3),
hybridization of annealer oligonucleotides (1C4), and ligation,
washing, scanning, and quantification of hexamer arrays (1C5–C7).
PCR amplification (Fig. 1C2) Biotinylated PCR products
were obtained using sense biotinylated Vb primers against reverse,
antisense Cb or Jb primers (PCR conditions as described above).
For the analysis of CMV-cells in vivo (Fig. 5), cDNA was
synthesized using the smart PCR cDNA synthesis kit (Clontech,
Mountain View, CA).
Isolation of single strands (Fig. 1C3) 1.0 mg streptavidin-
coated magnetic beads (M-280 Dynabeads, Dynal Biotech, Oslo,
N) were washed twice in B&W buffer (Dynal Biotech, Oslo, N) and
biotinylated PCR products were linked to the magnetic beads
according to the suppliers protocol. Non-bound DNA and
nucleotides were removed by washing in 1x and subsequently
0.46 B&W buffer. The non-biotinylated single strands were
released by 10 minutes incubation in 0.15 N NaOH. After
magnetic separation, supernatant containing the non-biotinylated
single strands was pH neutralized using neutralization buffer (0.75
HCl, 0.125 M Tris, 16.7 mM MgCl2, 1.67 mM DTT).
Hybridization of annealer oligonucleotides (Fig.
1C4) Single strands were then incubated with 1 pmol Cy5-
labeled, 59 phosphorylated annealer oligonucleotide (Biolegio,
Malden, NL) at a starting temperature of 90uC. The heated water
bath was (passively) cooled to ambient temperature. Sequences
of used annealer oligonucleotides are CTAACTATGGC-
TACACCTTCGGTTT (Fig. 2,3), AAACTGCTGGCACAGA-
AGTACACTT (Fig 2d,e), ACTATGGCTACACCTTCGGTT
(Fig. 4) and CTACGAGCAGTACTTCGGG (Fig. 5).
Ligation, washing, scanning, and quantification (Fig. 1C5–
C7) Ligation on arrays (Accessarray, Expresson Biosystems,
Roslin, UK) was performed at 30uC in a volume of 125 mli n
16 BSA (NEB, Ipswich, MA), 25 ml5 6 DNA Ligase buffer, 12
units T4 DNA ligase. After ligation slides were washed in 0.1%
SDS at 90uC, ddH2O at RT, and dried by 5006g centrifugation
for 3 minutes. Ligated arrays were scanned with a GSI Lumonics
ScanArray 5000 (Perkin-Elmer Life Sciences, Boston, MA). Spot
intensities were quantified using with ArrayVision 6.0 software
(Image Research, St. Catharines, Ontario, CDN).
T-array data in a format according to the MIAME guidelines
checklist www.mged.org/Workgroups/MIAME/miame_checklist.
html are available on request.
Ligation in solution
For experiments shown in Fig. 2B–E, ligation was performed in
solution with single hexamer oligonucleotides. 1 pmol of hexamers,
4 units of T4 DNA ligase and 2 ml5 6 DNA Ligase buffer (In
vitrogen - Life Technologies, Breda, NL) and template/annealer
complex were added in a total volume of 10 ml and incubated for
45 minutes at 16uC, followed by a 10 minutes denaturation step at
65uC. Ligation products were analyzed on the ABI Prism 3100
Genetic Analyzer capillary system and Genescan software as
described above.
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Figure S1 Semi-quantitative PCR Jurkat cells and CD4+ cells.
Found at: doi:10.1371/journal.pone.0000055.s001 (0.06 MB
DOC)
Figure S2 Germ line signals in T-array.
Found at: doi:10.1371/journal.pone.0000055.s002 (0.05 MB
DOC)
Table S1 N-deletion in 192 TCRb sequences from public
databases.
Found at: doi:10.1371/journal.pone.0000055.s003 (0.51 MB
DOC)
Table S2 Maximum resolution for spectratyping and T-array
protocol.
Found at: doi:10.1371/journal.pone.0000055.s004 (0.06 MB
DOC)
Table S3 Signal intensity T arrays.
Found at: doi:10.1371/journal.pone.0000055.s005 (0.12 MB
DOC)
Table S4 Comparing T-array signals to results from cloning and
sequencing in the ex vivo CMV-stimulation experiment.
Found at: doi:10.1371/journal.pone.0000055.s006 (0.29 MB
DOC)
Table S5 T-array analysis of CMV-specific cells in vivo.
Found at: doi:10.1371/journal.pone.0000055.s007 (0.07 MB
DOC)
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